Gabriel Sampaio Froehner

Gabriel Sampaio Froehner

Auto-generated profile, based on publicly available information

Gabriel Sampaio Froehner

From the Neurology Unit (G.S.F., H.A.G.T.), Federal University of Paraná, Curitiba; Internal Medicine Department (G.L.F.), Pontifical Catholic University of Paraná, Curitiba; and Internal Medicine Department (A.T.M.), Federal University of Paraíba, João Pessoa, Brazil

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Parkinson's Disease
Verified
Journal Article
Open access
PDF file
GFGiorgio Fabiani
Giorgio Fabiani
CCCarlos Henrique Camargo
Carlos Henrique Camargo
RFRaul Martins Filho
Raul Martins Filho
GFGabriel Sampaio Froehner
Gabriel Sampaio Froehner
HTHélio Afonso Ghizoni Teive
Hélio Afonso Ghizoni Teive
Introduction. Brain SPECT with 99mTc‐TRODAT‐1 (SPECT‐TRODAT) may be a useful tool in the differential diagnosis of Parkinsonism. Objective. To compare results of SPECT‐TRODAT with clinical findings in patients with Parkinsonism. Methods. We evaluated 153 outpatients. SPECT‐TRODAT results were visually analyzed into normal, abnormal, symmetric, and asymmetric, and according to the degree of impairment into mild, moderate, marked, and severe (1–4). Results. A direct relationship was found between motor scores severity (MDS‐UPDRS‐III) and SPECT‐TRODAT‐reduced binding in general, in the group of patients with synucleinopathies (rho = 0.258, p = 0.005), especially in patients with Parkinson’s disease (rho = 0.204, p = 0.049). Changes in SPECT‐TRODAT had high correspondence with symmetry in all Parkinsonism. When comparing groups to the correspondence predominantly bilateral or unilateral impairment in SPECT, there was a difference between patients with SNP (p = 0.041) and between this group and patients with secondary Parkinsonism (SP) (p < 0.0001). It was handy in differentiating drug‐induced Parkinsonism from synucleinopathies. In the group of drug‐induced Parkinsonism, younger people were the ones who showed the most significant reductions in radiotracer uptake. In this group, nonmotor signs resulted in examinations with more significant reductions in radiotracer uptake. When the scans without alterations and those that did not correspond to the symmetry were considered negative, SPECT‐TRODAT’s accuracy and specificity to differentiate PD from other forms of Parkinsonism were low. There was an inverse correlation between the severity of the SPECT‐TRODAT result and the absence of nonmotor signs in patients with drug‐induced Parkinsonism. Conclusion. The authors concluded that the SPECT with 99mTc‐TRODAT‐1 was mainly useful in differentiating between synucleinopathies and secondary Parkinsonism.

28 September 2022 in The Open Neurology Journal
Verified
Journal Article
Open access
PDF file
GFGabriel Sampaio Froehner
Gabriel Sampaio Froehner
CCCarlos Henrique Camargo
Carlos Henrique Camargo
GFGiorgio Fabiani
Giorgio Fabiani
AMAlex Tiburtino Meira
Alex Tiburtino Meira
RFRaul Martins Filho
Raul Martins Filho
HTHélio Afonso Ghizoni Teive
Hélio Afonso Ghizoni Teive
Introduction: Patients with essential tremor (ET) have 3.5 times greater risk of developing Parkinson's disease (PD) throughout their lives, also known as PD with antecedent ET (ET-PD). Single photon emission computed tomography with radiotracer imaging of dopamine transporters (TRODAT-SPECT) can help differentiate these two diseases. Method: Relate the results of TRODAT-SPECT imaging in patients with ET to potential progress to ET-PD. Thirty-six patients with ET were evaluated by neurological examination, the Archimedes spiral, and the MDS-UPDRS III scale on two occasions, after a mean interval of three years. SPECT was performed on all patients after the first visit. Results: Overall, six patients (16.6%) progressed clinically to ET-PD. Patients with ET-PD were older, and the age of tremor onset was later. The ET-PD group scored higher on the MDS-UPDRS III scale, especially for the presence of bradykinesia. SPECT imaging was altered in 83.3% of the ET-PD patients compared to 33% of the ET patients (p=0.034). Changes on the SPECT with asymmetrical hypouptake suggested progress to ET-PD (p=0.025). Conclusion: Advanced age at the onset of tremor, the presence of bradykinesia, and asymmetrical alterations in SPECT may be related to progression to PD in patients with ET. Changes in neuroimaging suggest that SPECT-TRODAT can be used to predict progression to PD in selected patients.

1 December 2020 in Arquivos de Neuro-Psiquiatria
Verified
Journal Article
Open access
PDF file
AMAlex Tiburtino Meira
Alex Tiburtino Meira
APAnieli Fagiani Prodóssimo
Anieli Fagiani Prodóssimo
GFGabriel Sampaio Froehner
Gabriel Sampaio Froehner
GFGustavo Leite Franklin
Gustavo Leite Franklin
MMMurilo Sousa DE Meneses
Murilo Sousa DE Meneses
HTHélio Afonso Ghizoni Teive
Hélio Afonso Ghizoni Teive
The authors review the role of Jules Bernard Luys in the discovery of the subthalamic nucleus (STN) over 150 years ago. The relationships between the STN and movement disorders, particularly hemiballismus and Parkinson’s disease, are well known. The academic life of Jules Bernard Luys can be divided into two periods: a brilliant start as a neuroanatomist, culminating in the discovery of the STN, followed by a second period marked by a shift in his academic activity and an increased interest in topics such as hysteria, hypnotism and, eventually, esotericism.

24 October 2023 in Neurology
Verified
Journal Article
Closed access
PDF file
GFGabriel S. Froehner
Gabriel S. Froehner
GFGustavo L. Franklin
Gustavo L. Franklin
AMAlex T. Meira
Alex T. Meira
HTHélio Afonso Ghizoni Teive
Hélio Afonso Ghizoni Teive